Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bronchodilator Response in Children With Bronchiolitis
NCT06946264Phase 3Recruiting
- Sponsor
- Nemours Children's Health
- Start
- Jul 2022
- Primary completion
- Dec 2029
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of albuterol dry powder inhaler in bronchiolitis (2 arms), sponsored by Nemours Children's Health. Primary endpoints: Minimum Clinically Important Difference and Candidate genetic variants at 1 year. Started Jul 2022; status: recruiting.
02
Drugs
albuterol dry powder inhaler
03
Conditions
bronchiolitis
Beyond the preview
Go deeper on NCT06946264.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06946264.